| Dendritic cell vaccine immunotherapy; the beginning of the end of cancer and COVID-19. A hypothesis MK Saadeldin, AK Abdel-Aziz, A Abdellatif Medical hypotheses 146, 110365, 2021 | 44 | 2021 |
| Anti-diabetic effects of fenugreek (Trigonella foenum-graecum): A comparison between oral and intraperitoneal administration-an animal study ME Baset, TI Ali, H Elshamy, AM El Sadek, DG Sami, MT Badawy, ... International journal of functional nutrition 1 (1), 1-1, 2020 | 41 | 2020 |
| Serum sclerostin and irisin as predictive markers for atherosclerosis in Egyptian type II diabetic female patients: A case control study MK Saadeldin, SS Elshaer, IA Emara, M Maged, AK Abdel-Aziz PLoS One 13 (11), e0206761, 2018 | 40 | 2018 |
| Effects of Turmeric (Curcuma longa) Extract in streptozocin‐induced diabetic model AA R Essa, AM El Sadek, ME Baset, MA Rawash, DG Sami, MT Badawy, ME Mansour ... Journal of Food Biochemistry, doi.org/10.1111/jfbc.12988, 2019 | 32* | 2019 |
| Tuning mTORC1 activity dictates the response of acute myeloid leukemia to LSD1 inhibition AK Abdel-Aziz, I Pallavicini, E Ceccacci, G Meroni, MK Saadeldin, ... haematologica 105 (8), 2105, 2020 | 28* | 2020 |
| New genetic variants of LATS1 detected in urinary bladder and colon cancer MK Saadeldin, H Shawer, A Mostafa, NM Kassem, A Amleh, R Siam Frontiers in Genetics 5, 425, 2015 | 15 | 2015 |
| Preclinical models of breast cancer: Two-way shuttles for immune checkpoint inhibitors from and to patient bedside AK Abdel-Aziz, MK Saadeldin, P D'Amico, S Orecchioni, F Bertolini, ... European Journal of Cancer 122, 22-41, 2019 | 9 | 2019 |
| Thermal stability of a mercuric reductase from the Red Sea Atlantis II hot brine environment as analyzed by site-directed mutagenesis M Maged, A El Hosseiny, MK Saadeldin, RK Aziz, E Ramadan Applied and Environmental Microbiology 85 (3), e02387-18, 2019 | 7 | 2019 |
| A Critical Review of Chloroquine and Hydroxychloroquine as Potential Adjuvant Agents for Treating People with Cancer AK Abdel-Aziz, MK Saadeldin, AH Salem, SA Ibrahim, S Shouman, ... Future Pharmacology 2 (4), 431-443, 2022 | 6 | 2022 |
| Indolin-2-one derivatives as selective Aurora B kinase inhibitors targeting breast cancer EME Dokla, AK Abdel-Aziz, SN Milik, AH Mahmoud, MK Saadeldin, ... Bioorganic Chemistry 117, 105451, 2021 | 6 | 2021 |
| Insights into the design of inhibitors of the EGFR family with anticancer activity overcoming resistance: A case of optimizing thieno [2, 3-d] pyrimidine-based EGFR inhibitors SN Milik, AK Abdel-Aziz, MM El-Hendawy, RI El-Gogary, MK Saadeldin, ... Journal of Molecular Structure 1259, 132724, 2022 | 5 | 2022 |
| FLT3 inhibitors and novel therapeutic strategies to reverse AML resistance: an updated comprehensive review AK Abdel-Aziz, EME Dokla, MK Saadeldin Critical Reviews in Oncology/Hematology, 104139, 2023 | 3 | 2023 |
| Unleashing nature's potential and limitations: Exploring molecular targeted pathways and safe alternatives for the treatment of multiple sclerosis S Fathallah, A Abdellatif, MK Saadeldin Medicine international 3 (5), 1-13, 2023 | 1 | 2023 |
| The pancancer overexpressed NFYCAntisense 1 controls cell cycle mitotic progression through in cis and in trans modes of action C Pandini, G Pagani, M Tassinari, E Vitale, E Bezzecchi, MK Saadeldin, ... Cell Death & Disease 15 (3), 206, 2024 | | 2024 |
| Goat PRP14 (gPRP14) has xeno-antigenic properties and works as a vaccine in preclinical models of cancer S Minucci, B Bussolati, PE Massa, A Brossa, R Ravasio, M Saadeldin, ... bioRxiv, 2022.07. 04.498594, 2022 | | 2022 |
| Highlights from the ‘Noncoding RNA world: From Mechanism to Therapy’conference, July 21-23, 2021 MK Saadeldin World Academy of Sciences Journal 3 (6), 1-5, 2021 | | 2021 |
| Molecular variation of the tumor suppressor gene LATS1 in urinary bladder cancer and colon cancer in Egyptian patients MKSA Saadeldin American University in Cairo, 2013 | | 2013 |
Amal Kamal Abdel-AzizAssociate Professor of Pharmacology & Toxicology, ASU and Postdoctoral Pharmacologist, IEO, ItalyVerified email at pharma.asu.edu.eg
